Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Testing documentation varies by sellable lot
doi:10.1002/bdr2.1466
Pharmacol Res (2018) 137:21929
This reflects several practical and risk-management considerations: Feasibility: 10 mg represents a testable dose that fits typical tablet manufacturing and is easy to dose consistently Precaution: It is substantially lower than the upper range of animal studies when adjusted for expected human bioavailability Tolerability: Community reports suggest 10 mg daily is generally well-tolerated in most users without major adverse effects Observability: At lower doses, any effects (beneficial or adverse) are more likely to be attributable to Dihexa rather than confounding factors Cost-effectiveness: 10 mg balances efficacy expectations with pricing practicality However, "conservative" and "well-tolerated at low doses" does not mean "safe." The absence of clinical trial data means individual responses are unpredictable
Although further research is required in order to better understand its mechanisms and efficacy in practical settings, BPC 157 has the potential to be developed as a new therapy to conservatively treat or aid recovery following surgery in typically hypovascular and hypocellular soft tissues such as tendon and ligament tissue
US$ 29.74
US$ 26.19
US$ 20.84
US$ 22.31
US$ 21.20
US$ 27.22
US$ 23.80
US$ 27.31
